Paul Mussenden
Director/Board Member bei DRI HEALTHCARE TRUST
Vermögen: - $ am 31.03.2024
Profil
Paul Justin Mussenden is currently the Chief Executive Officer at Cydar Ltd.
since 2020.
He is also the Deputy Chairman at Lifearc since 2014, the Chairman at DRI Healthcare Plc since 2019, and an Independent Trustee at DRI Healthcare Trust since 2021.
Previously, he worked at BTG Ltd.
from 2000 to 2019, where he held the position of General Counsel & Head-Strategic Affairs from 2010 to 2019.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
DRI HEALTHCARE TRUST
-.--% | 19.04.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Paul Mussenden
| Unternehmen | Position | Beginn |
|---|---|---|
| DRI HEALTHCARE TRUST | Director/Board Member | 22.01.2021 |
Lifearc
 Lifearc Miscellaneous Commercial ServicesCommercial Services Lifearc provides research services. It specializes in intellectual property management, drug discovery, medical diagnostics and antibody engineering. The firm services include complete technology transfer service for scientists in MRC units and institutes, Awards to Inventors, Collaborative drug discovery and antibody engineering, Funding early stage research with commercial/translational potential and protecting new ideas. The company is headquartered in London, the United Kingdom. | Director/Board Member | 01.06.2014 |
Cydar Ltd.
 Cydar Ltd. Packaged SoftwareTechnology Services Cydar Ltd. develops computer vision software applications. Its Cydar EV is the AI-powered image fusion platform. The company was founded by Tom Carrell and Graeme Penney in 2012 and is headquartered in Barrington, the United Kingdom. | Chief Executive Officer | 01.10.2020 |
DRI Healthcare Plc
 DRI Healthcare Plc Investment ManagersFinance DRI Healthcare Plc is a closed-ended investment company, which invests in a portfolio of cash flow generating healthcare royalty assets. The company was founded on December 13, 2019 and is headquartered in London, the United Kingdom. | Chairman | 13.12.2019 |
Ehemalige bekannte Positionen von Paul Mussenden
| Unternehmen | Position | Ende |
|---|---|---|
| BTG | General Counsel | 01.08.2019 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| DRI HEALTHCARE TRUST | Miscellaneous |
| Private Unternehmen | 4 |
|---|---|
BTG Ltd.
 BTG Ltd. Pharmaceuticals: MajorHealth Technology BTG Ltd. is a global healthcare company, which focuses on interventional medicine that can help physicians to treat patients through minimally invasive procedures. It operates through the following segments: Product, Licensing, and Other. The firm's products include CroFab, DigiFab, Voraxage. The company was founded on December 12, 1991 and is headquartered in Farnham, the United Kingdom. | Health Technology |
Lifearc
Lifearc Miscellaneous Commercial ServicesCommercial Services Lifearc provides research services. It specializes in intellectual property management, drug discovery, medical diagnostics and antibody engineering. The firm services include complete technology transfer service for scientists in MRC units and institutes, Awards to Inventors, Collaborative drug discovery and antibody engineering, Funding early stage research with commercial/translational potential and protecting new ideas. The company is headquartered in London, the United Kingdom. | Commercial Services |
Cydar Ltd.
Cydar Ltd. Packaged SoftwareTechnology Services Cydar Ltd. develops computer vision software applications. Its Cydar EV is the AI-powered image fusion platform. The company was founded by Tom Carrell and Graeme Penney in 2012 and is headquartered in Barrington, the United Kingdom. | Technology Services |
DRI Healthcare Plc
DRI Healthcare Plc Investment ManagersFinance DRI Healthcare Plc is a closed-ended investment company, which invests in a portfolio of cash flow generating healthcare royalty assets. The company was founded on December 13, 2019 and is headquartered in London, the United Kingdom. | Finance |
